26 May 2013
Keywords: wyeth/progenics, initiate, ph, iii, trial, poi, treatment
Article | 22 December 2006
Drug major Wyeth and fellow USA-based Progenics Pharmaceuticals have initiated the second of two global, pivotal Phase III clinical trials ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
18 December 2006
24 May 2013
© 2013 thepharmaletter.com